JPMorgan Chase & Co. Invests $26,000 in Silence Therapeutics plc (NASDAQ:SLN)
JPMorgan Chase & Co. purchased a new stake in Silence Therapeutics plc (NASDAQ:SLN – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 3,793 shares of the company’s stock, valued at approximately $26,000. Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing […]
JPMorgan Chase & Co. purchased a new stake in Silence Therapeutics plc (NASDAQ:SLN – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 3,793 shares of the company’s stock, valued at approximately $26,000. Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
